Company Filing History:
Years Active: 2021-2022
Title: Innovations by Joel Haaf in Brain Treatment Technologies
Introduction
Joel Haaf is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of medical technology, particularly in brain treatment systems. With a total of two patents to his name, Haaf's work focuses on improving patient outcomes through innovative solutions.
Latest Patents
Haaf's latest patents include the "Ablation Result Validation System" and the "Treatment Trajectory Guidance System." The Ablation Result Validation System provides devices, systems, and methods for validating ablation results in a patient's brain. This method involves obtaining magnetic resonance (MR) data and first imaging data of the patient's brain, extracting first fiber tracts, and comparing them with second fiber tracts after the ablation process has started. The graphical representation of this comparison aids in assessing the effectiveness of the treatment.
The Treatment Trajectory Guidance System offers methods for guiding treatment trajectories in a patient's brain. This system includes obtaining a three-dimensional (3D) brain model and modifying it based on MR data. The modified model allows for the display of a planned trajectory for treatment and an estimated treatment result, enhancing the precision of medical interventions.
Career Highlights
Joel Haaf is currently employed at Koninklijke Philips Corporation N.V., where he continues to develop innovative medical technologies. His work is instrumental in advancing the capabilities of brain treatment systems, contributing to better patient care and outcomes.
Collaborations
Haaf collaborates with Lyubomir Georgiev Zagorchev, working together to push the boundaries of medical technology and improve treatment methodologies.
Conclusion
Joel Haaf's contributions to brain treatment technologies through his patents reflect his commitment to innovation in the medical field. His work at Koninklijke Philips Corporation N.V. continues to pave the way for advancements that can significantly impact patient care.